Two Sigma Investments
NVIV

Two Sigma Investments’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Two Sigma Investments’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,521
Closed -$49K – 3238
2022
Q3 		$49K Buy
+11,521
New +$63.1K ﹤0.01% 2320
2020
Q3 		– Sell
-631
Closed -$25K – 3778
2020
Q2 		$25K Buy
+631
New +$24.6K ﹤0.01% 2861
2018
Q4 		– Sell
-15
Closed -$23K – 3813
2018
Q3 		$23K Buy
+15
New +$22.1K ﹤0.01% 3112

Other funds holding NVIV

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments's NVIV Position: Q4 2022 in Review

Two Sigma Investments sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2022, closing a stake of 11,521 shares — an estimated $49K sold.

Two Sigma Investments first reported a position in NVIV in Q3 2018 and held it in 3 quarters. The position peaked at $49K in Q3 2022. 18 funds tracked by Wall St. Rank hold NVIV as of Q4 2022.

  • Two Sigma Investments reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 11,521 InVivo Therapeutics Holdings Corp shares in Q4 2022, an estimated $49K.
  • Two Sigma Investments first reported a position in InVivo Therapeutics Holdings Corp in Q3 2018 and held it in 3 quarters.
  • Two Sigma Investments's InVivo Therapeutics Holdings Corp position peaked at $49K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.